Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

PerkinElmer plans to acquire Pediatrix's newborn metabolic screening business

PerkinElmer : 20 December, 2007  (New Product)
PerkinElmer is to acquire the newborn metabolic screening business of Pediatrix Medical Group in a cash transaction.
Under the terms of the agreement, PerkinElmer will acquire Pediatrix's metabolic screening laboratory and its StepOne newborn screening product that is capable of analysing more than 50 inherited disorders in newborns.

Currently, Pediatrix's screening laboratory provides neonatal screening and consultative services to hospitals, medical groups, and the states of Maryland, Mississippi, Louisiana, Nebraska and Pennsylvania, as well as the District of Columbia. Since its founding in 1994, the laboratory has screened more than three million babies, and is anticipated to generate revenues of approximately $15 million in 2007.

'This announcement builds on our strategy to expand the capabilities of our Genetic Screening business to protect the health of mothers and babies from pregnancy to birth and beyond,' said Gregory L Summe, chairman and chief executive officer of PerkinElmer. The company recently completed the acquisition of ViaCell, providing it with ViaCord, a leading cord blood preservation service. Summe continued, 'PerkinElmer is building an enhanced capability to deliver a growing portfolio of world-class neonatal and prenatal/maternal health solutions to consumers through their healthcare professionals.'

'This acquisition would expand PerkinElmer's capabilities to supply state laboratories with the most comprehensive newborn screening solutions available,' said Robert F Friel, president and chief operating officer, PerkinElmer. 'Adding laboratory capabilities should strengthen the partnership with our existing customers by enabling us to offer supplemental screening services for disorders beyond those currently mandated by state and federal governments. In addition, we would be able to provide our customers with supplemental support services, such as potential back-up screening capabilities in the event of emergencies.'

PerkinElmer and Pediatrix Medical Group intend to collaborate on future research to identify possible applications for tandem mass spectrometry technology in prenatal and neonatal testing and diagnostics that might improve patient care. Pediatrix Medical Group will continue to operate its separate, internally developed newborn hearing screen program, a hospital-based service that screens for possible hearing loss, usually prior to a newborn's discharge.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo